Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2989 (LINC02989) is a human long non-coding RNA (lncRNA), classified as a non-protein-coding transcript located in intergenic regions of the genome[5][3][1]. As an lncRNA, LINC02989 is part of a broad class of transcripts (lncRNAs) that do not encode proteins but can be involved in the regulation of gene expression and chromatin structure[5][7][8]. While lncRNAs collectively have diverse roles in development, differentiation, and disease—including cancer—there is currently *no direct evidence* that LINC02989 itself functions as a therapeutic target, disease biomarker, or drug-interacting molecule[5][7][8]. No specific biological processes or disease associations for this lncRNA have been characterized in detail, and it is not listed as a target for any known drugs. The aliases include both "LINC02989" and the less common "lnc-MICAL2-1"[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2989 (LINC02989).